Health Equity

A new pact between BioSTL and the UK's NHS is set to make St. Louis a prime U.S. launchpad for health tech, turning global innovation into local impact.

Dr. Aida Habtezion’s leap from Pfizer to the board of Bio Usawa is more than a career move; it’s a key signal in the race to build Africa’s medical independence.

Susan Solomon's Tang Prize for her work on the ozone layer isn't just an award. It's a signal pointing to a powerful blueprint for global cooperation.

A major data breach at Ohio Living exposes sensitive patient and employee data, echoing a past failure and signaling a deepening crisis for the entire sector.

Jurupa Community Services District's national recognition isn't just an award; it's a strategic model for how investing in people drives superior service.

KPJ Healthcare launches a kidney transplant service, a strategic move addressing a national health crisis and reviving a fifty-year-old medical legacy.

While others chase flashy tech, LG's new Comfort Kit proves that small, thoughtful design changes can make the biggest difference in creating a home for all.

Blue Cross and Blue Shield of Texas is betting on a new copay-only plan to cut costs without shrinking networks. Can its 'Easify' platform guide us to a simpler healthcare future?

The global toy market is no longer child's play. A new report reveals a $123B industry transformed by adult collectors, digital natives, and blurring lines.

Alto's proposed high-speed rail promises a $1B GDP boost and a tourism revolution. But with a $90B price tag and mounting opposition, can this dream become reality?

A new app, born from its founder's personal health battle, challenges the 'no pain, no gain' ethos of digital wellness with a flexible, empathetic model.

MAIA Biotechnology isn't just opening a new trial site; it's accelerating its assault on a $70B market with a drug showing remarkable early results.

Replacing a controversial task force, Canada's new NACPHS aims to modernize health guidelines with a focus on equity, patient input, and scientific agility.

NBA legend Shaquille O'Neal's campaign for Zepbound spotlights a silent health epidemic, but the drug's high cost and the ethics of celebrity ads loom large.

Federal cuts are pushing 450,000 New Yorkers off the Essential Plan. Here’s what you need to know to avoid a coverage gap and find a new plan now.

At EHA 2026, Parexel isn't just presenting data; it's unveiling a bold new strategy to fix a broken system and accelerate life-saving blood cancer drugs.

With its pivotal Phase 3 trial complete, Rafael Holdings is on a path to redefine treatment for NPC and transform itself into a commercial-stage biotech.

One in six people globally faces infertility, yet a pervasive stigma silences their struggle. A worldwide movement is now uniting millions to demand change.

A global health giant is now targeting the world's financial system, arguing that crippling debt is a deadlier crisis than any disease. Is their plan a revolution or a fantasy?

Asante and WesternU launch a strategic partnership to embed medical students in the Rogue Valley, tackling physician shortages with a 'grow your own' model.